Skip to main content

Boehringer Ingelheim and Ashoka host co-creation workshop under 'Making More Health' program

Staff during the MMH workshop
Boehringer Ingelheim, one of the world’s leading pharmaceutical companies, and Ashoka, the world's largest network of social entrepreneurs, have held a co-creation workshop for the ‘Making More Health’ (MMH) Accelerator in Nairobi, Kenya. The MMH Accelerator program supports social entrepreneurs in the healthcare space to strengthen and scale their work. The program brings together some of the best experiences in social innovation and global health to improve access to healthcare systemsacross Sub-Saharan Africa.

Along with capacity building as well as technical and financial support to develop, pilot and test their co-creation ideas with Boehringer Ingelheim and Ashoka, the social entrepreneurs participating in the program will receive trainings on business model innovation, market strategy and scaling models. Through the accelerator process, social entrepreneurs participating in the Accelerator will have access to a network of professional support, including Boehringer Ingelheim and Ashoka experts.

The MMH Accelerator combines Ashoka’s expertise in social entrepreneurship with Boehringer Ingelheim’s business acumen and knowledge of the healthcare industry. The participating projects address several themes such as providing medical care in remote areas in a more effective and sustainable manner, digital platforms that support integrated care for patients with chronic diseases, and increasing transparency within the pharmaceutical supply chain.

In order to place patients at the core of their care, it is imperative that they receive the right treatment paradigm. Through various programs and activities, Boehringer Ingelheim contributes to providing healthcare solutions and access across Africa, with structured activities that range from adequate awareness building and prevention of diseases, training and education of healthcare professionals, technology transfer as well as social innovation.

Simon Manyara, Access to Healthcare Manager at Boehringer Ingelheim commented, “Over the years, our social initiatives in Kenya have been connecting people with timely and effective healthcare solutions. These co-creation thinking workshops, as part the accelerator, are helping address the most critical topics. We want to foster local social innovation and increase access to healthcare among underserved communities and strengthen the potential of these projects through the immense knowledge pool within our talent and global operations network.”

MMH is a core driver of social entrepreneurship, innovation and co-creation for Boehringer Ingelheim across the world. Other social healthcare initiatives that have been developed under the Ashoka and Boehringer Ingelheim partnership include iSikCure, an application developed to improve access to quality care and safe medicine. Similarly, in 2017, working with Access Afya and Pharm Access Foundation, Boehringer Ingelheim launched Akiba Ya Roho, a micro-savings and disease management program that aims to drive more healthcare awareness and overall understanding and management of non-communicable disease in Kenya. The mobile wallet solution provides a technical platform that allows individuals to send, save and spend funds for medical treatment and savings management.

Launched in 2010 to mark the 125th years of Boehringer Ingelheim, MMH is a global social entrepreneurial initiative that seeks to support the health of people, their families and the social environment by identifying and supporting promising solutions to improve health systems globally.

Comments

Popular posts from this blog

Column: Caleb Otieno: Make empathy a reflex

‘Empathy is about standing in someone else 's shoes, feeling with his or her heart, seeing with his or her eyes. Reflection is the means of processing thoughts and feelings about an activity, incident, or day. It gives us a chance to come to terms with our thoughts and feelings surrounding it”  People who understand how to watch, listen and observe the actions and emotions of those around them are often perceived as the most successful in life. A conscious alignment of one’s self with others starts with the development of empathy in the early years.  In the early years of life from age two to seven, young children are naturally ego-centric and are very much inclined to think mostly about themselves and their immediate needs. They are not yet ready to consider the needs and feelings of others. Developing a sense of empathy is an important developmental process for young children. It is at the heart of good relationships, and it begins with valuing others and their perspectives.  Tea

New Research Finds Corner Shops are Faring Well Against Big Box Stores in Emerging Markets

Today,   Flourish Ventures   released a new research report showing that corner shops are doing better than predicted despite protracted supply chain issues and big-box and online retail competitors. The study confirmed better-than-expected sales and that 94% of consumers surveyed plan to shop as much or more at their corner shops in the future. Both shopkeepers and customers believe, however, that corner stores will need to accelerate digital technology adoption to remain relevant and competitive.                                                                                                                                                   The  2022 Digitizing the Corner Shop  research report, published by Flourish, a global fintech investor in partnership with Bain & Company and 60 Decibels, elevates the voices of more than 800 shopkeepers and 800 of their customers in Brazil, Egypt, India, and Indonesia. These primary research findings and accompanying Flourish analysis provide

Novo Nordisk opens regional office in Kenya

From left: Pharmacy and Poisons Board CEO Dr Fred Siyoi, Denmark Deputy Ambassador to Kenya Henrik Larsen and Novo Nordisk's Vice President (Business Area Africa and Gulf) Mads Bo Larsen during the opening of Novo Nordisk's Nairobi Office Novo Nordisk, a global healthcare company headquartered in Denmark with more than 95 years of innovation and leadership in diabetes care has opened a regional office in Nairobi, Kenya. Medicine is their key contribution and they supply nearly half of the world’s insulin. However, it takes more than medicine to defeat diabetes. The company, therefore, works in partnerships to drive change to defeat diabetes. Some of the key projects in Kenya include the Base of the Pyramid (BoP) project that works to improve access to diabetes care for people at the base of the economic pyramid and the Changing Diabetes® in Children (CDiC) programme that aims to bring all elements of necessary diabetes care closer to the children and build capacity for